The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
Quantifying the role of PSA screening in the US prostate cancer mortality decline
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cost-Effectiveness in Health and Medicine
(1996) · doi:10.1093/oso/9780195108248.001.0001 · Cited by 7,193
The Influence of Finasteride on the Development of Prostate Cancer
Thompson, I. M., Goodman, P. J., Tangen, C. M., Lucia, M. S., Miller, G. J., Ford, L. G., Lieber, M. M., Cespedes, R. D., Atkins, J. N., Lippman, S. M., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa030660 · Cited by 2,518
Effect of Screening and Adjuvant Therapy on Mortality from Breast Cancer
Berry, D. A., Cronin, K. A., Plevritis, S. K., Fryback, D. G., Clarke, L., Zelen, M., Mandelblatt, J. S., Yakovlev, A. Y., Habbema, J. D. F., & Feuer, E. J. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa050518 · Cited by 2,460
Self-citationSathianathen, N. (2021) · 50 Studies Every Urologist Should Know · doi:10.1093/med/9780190655341.003.0002 · Cited by 2,080
Radical Prostatectomy versus Watchful Waiting in Early Prostate Cancer
Bill-Axelson, A., Holmberg, L., Ruutu, M., Garmo, H., Stark, J. R., Busch, C., Nordling, S., Häggman, M., Andersson, S.-O., Bratell, S., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1011967 · Cited by 1,900
Bolla, M., Collette, L., Blank, L., Warde, P., Dubois, J. B., Mirimanoff, R.-O., Storme, G., Bernier, J., Kuten, A., Sternberg, C., et al. (2002) · The Lancet · doi:10.1016/s0140-6736(02)09408-4 · Cited by 1,686 · cited 1×
“Both of these treatment approaches have shown benefit in randomized studies [15, 16].”
BackgroundRadical Prostatectomy versus Watchful Waiting in Early Prostate Cancer
Bill-Axelson, A., Holmberg, L., Ruutu, M., Häggman, M., Andersson, S.-O., Bratell, S., Spångberg, A., Busch, C., Nordling, S., Garmo, H., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa043739 · Cited by 1,111
Draisma, G., Boer, R., Otto, S. J., van der Cruijsen, I. W., Damhuis, R. A. M., Schroder, F. H., & de Koning, H. J. (2003) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/95.12.868 · Cited by 1,071
Etzioni, R. (2002) · CancerSpectrum Knowledge Environment · doi:10.1093/jnci/94.13.981 · Cited by 949
Self-citationA COMPARATIVE ANALYSIS OF SEXTANT AND AN EXTENDED 11-CORE MULTISITE DIRECTED BIOPSY STRATEGY
BABAIAN, R. J., TOI, A., KAMOI, K., TRONCOSO, P., SWEET, J., EVANS, R., JOHNSTON, D., & CHEN, M. (2000) · Journal of Urology · doi:10.1016/s0022-5347(05)67993-1 · Cited by 456
National Practice Patterns and Time Trends in Androgen Ablation for Localized Prostate Cancer
Cooperberg, M. R., Grossfeld, G. D., Lubeck, D. P., & Carroll, P. R. (2003) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/95.13.981 · Cited by 329
de Koning, H. J., Auvinen, A., Berenguer Sanchez, A., Calais da Silva, F., Ciatto, S., Denis, L., Gohagan, J. K., Hakama, M., Hugosson, J., Kranse, R., et al. (2002) · International Journal of Cancer · doi:10.1002/ijc.1588 · Cited by 285
Feuer, E. J., Merrill, R. M., & Hankey, B. F. (1999) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/91.12.1025 · Cited by 251
Self-citationIncidence of Initial Local Therapy Among Men With Lower-Risk Prostate Cancer in the United States
Miller, D. C., Gruber, S. B., Hollenbeck, B. K., Montie, J. E., & Wei, J. T. (2006) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djj308 · Cited by 227
Lu-Yao, G., Albertsen, P. C., Stanford, J. L., Stukel, T. A., Walker-Corkery, E. S., & Barry, M. J. (2002) · BMJ · doi:10.1136/bmj.325.7367.740 · Cited by 216
Asymptomatic Incidence and Duration of Prostate Cancer
Etzioni, R., Cha, R., Feuer, E. J., & Davidov, O. (1998) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a009698 · Cited by 127
Self-citationTelesca, D., Etzioni, R., & Gulati, R. (2007) · Biometrics · doi:10.1111/j.1541-0420.2007.00825.x · Cited by 123
Self-citationThe Effectiveness of Screening for Prostate Cancer
Concato, J. (2006) · Archives of Internal Medicine · doi:10.1001/archinte.166.1.38 · Cited by 106
Etzioni, R., Gulati, R., Falcon, S., & Penson, D. F. (2008) · Medical Decision Making · doi:10.1177/0272989x07312719 · Cited by 105
Self-citationZeliadt, S. B., Potosky, A. L., Etzioni, R., Ramsey, S. D., & Penson, D. F. (2004) · Urology · doi:10.1016/j.urology.2004.07.037 · Cited by 94
Self-citationTRANSURETHRAL RESECTION OF THE PROSTATE AMONG MEDICARE BENEFICIARIES: 1984 TO 1997
Wasson, J. H., Bubolz, T. A., Lu‐Yao, G. L., Walker-Corkery, E. S., HAMMOND, C. S., & Barry, M. J. (2000) · The Journal of Urology · doi:10.1016/s0022-5347(05)67143-1 · Cited by 91
A population model of prostate cancer incidence
Tsodikov, A., Szabó, A., & Wegelin, J. (2006) · Statistics in Medicine · doi:10.1002/sim.2257 · Cited by 58
Self-citationEtzioni, R., Cha, R., & Cowen, M. E. (1999) · The Journal of Urology · doi:10.1097/00005392-199909010-00032 · Cited by 55
Self-citationCombining longitudinal studies of PSA
Inoue, L. Y. T., Etzioni, R., Slate, E. H., Morrell, C. H., & Penson, D. F. (2004) · Biostatistics · doi:10.1093/biostatistics/5.3.483 · Cited by 34
Self-citationAsymptomatic Incidence and Duration of Prostate Cancer
Etzioni, R., Cha, R., Feuer, E. J., & Davidov, O. (1999) · The Journal of Urology · doi:10.1097/00005392-199907000-00083 · Cited by 32
Self-citationChallenges to cancer control by screening
Pollak, M., & Foulkes, W. D. (2003) · Nature reviews. Cancer · doi:10.1038/nrc1042 · Cited by 26
Barry, M. J., Fleming, C., Coley, C. M., Wasson, J. H., Fahs, M. C., & Oesterling, J. E. (1995) · Urology · doi:10.1016/s0090-4295(99)80208-8 · Cited by 14
What is the value of screening for prostate cancer in the US?
Albertsen, P. C. (2005) · Nature Clinical Practice Oncology · doi:10.1038/ncponc0348 · Cited by 11
Does current evidence justify prostate cancer screening in Europe?
Martin, R. M., Smith, G. D., & Donovan, J. (2005) · Nature Clinical Practice Oncology · doi:10.1038/ncponc0349 · Cited by 10
Revisiting my personal decision about prostate‐specific antigen testing in 2005
Barry, M. J. (2005) · British Journal of Urology · doi:10.1111/j.1464-410x.2005.05796.x · Cited by 4
Cited by
Sung, H., Ferlay, J., Siegel, R. L., Laversanne, M., Soerjomataram, I., Jemal, A., & Bray, F. (2021) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21660 · Cited by 108,699
Bray, F., Laversanne, M., Sung, H., Ferlay, J., Siegel, R. L., Soerjomataram, I., & Jemal, A. (2024) · CA: a cancer journal for clinicians · doi:10.3322/caac.21834 · Cited by 27,064
“101,102 During the same period, rates increased in many countries in Central and Eastern Europe, Asia, and Africa 88 and continued until recently in some countries 86 , partly reflecting a concomitant increase in incidence rates alongside lesser access to PSA testing and curative treatment.”
BackgroundSiegel, R. L., Miller, K. D., & Jemal, A. (2020) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21590 · Cited by 20,444
Siegel, R. L., Miller, K. D., & Jemal, A. (2019) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21551 · Cited by 20,160
Siegel, R. L., Miller, K. D., Fuchs, H. E., & Jemal, A. (2021) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21654 · Cited by 16,522
Metadata
- Authors
- Etzioni, R., Tsodikov, A., Mariotto, A., Szabo, A., Falcon, S., Wegelin, J., diTommaso, D., Karnofski, K., Gulati, R., Penson, D. F., & Feuer, E.
- Venue
- Cancer Causes & Control
- Published
- 2007-11-20
- Volume
- 19
- Issue
- 2
- Pages
- 175-181
- ISSN
- 0957-5243 (ISSN-L)
- 1573-7225
- OpenAlex
- W2035446368
- Cited by
- 423
- References
- 30
- FWCI
- 11.98
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.